PMA supplement
P790032 S002: CLINICAL ASSAYS (TM) GAMMADAB(R) [ 125 I ]
FDA PMA supplement · Normal 180 Day Track · Incstar Corp.
Key facts
| Original PMA | P790032 |
|---|---|
| Supplement number | S002 |
| Supplement type | Normal 180 Day Track |
| Reason for the supplement | Location Change - Manufacturer/Sterilizer/Packager/Supplier |
| Trade name | CLINICAL ASSAYS (TM) GAMMADAB(R) [ 125 I ] |
| Generic name | KIT, TEST, ALPHA-FETOPROTEIN FOR NEURAL TUBE DEFECTS |
| Applicant | Incstar Corp. |
| Product code | LOK |
| Received date | Dec 24, 1990 |
| Decision date | Mar 28, 1991 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: